Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas (INIFTA), CCT-La Plata-CONICET, Universidad Nacional de La Plata, 1900 La Plata, Argentina.
Instituto de Nanosistemas (INS), Universidad Nacional de San Martin, 1650 San Martín, Argentina.
Nanomedicine (Lond). 2018 Jun;13(11):1349-1370. doi: 10.2217/nnm-2018-0010.
Silicon blue-emitting nanoparticles (NPs) are promising effectors for photodynamic therapy and radiotherapy, because of their production of reactive oxygen species (ROS) upon irradiation.
Amino-functionalized silicon NPs (NHSiNP) were intrinsically nontoxic below 100 μg/ml in vitro (on two tumor cell lines) and in vivo (zebrafish larvae and embryos). NHSiNP showed a moderate effect as a photosensitizer for photodynamic therapy and reduced ROS generation in radiotherapy, which could be indicative of a ROS scavenging effect. Encapsulation of NHSiNP into ultradeformable liposomes improved their skin penetration after topical application, reaching the viable epidermis where neoplastic events occur.
Subsequent derivatizations after amino-functionalization and incorporation to nanodrug delivery systems could expand the spectrum of the biomedical application of these kind of silicon NPs.
硅蓝色发光纳米粒子(NPs)由于其在辐照下产生的活性氧(ROS),是光动力疗法和放射疗法的有前途的效应物。
氨基功能化硅 NPs(NHSiNP)在体外(两种肿瘤细胞系)和体内(斑马鱼幼虫和胚胎)低于 100μg/ml 时具有固有低毒性。NHSiNP 作为光动力疗法的光敏剂表现出中等效果,并减少放射治疗中的 ROS 生成,这可能表明其具有 ROS 清除作用。将 NHSiNP 包封到超可变形脂质体中改善了其经皮应用后的皮肤穿透性,达到了发生肿瘤事件的活表皮。
氨基功能化和纳米药物递送系统后衍生化可以扩展此类硅 NPs 的生物医学应用范围。